Investor group presses drug companies on opioid controls


U.S. shareholder activists are addressing a soaring death toll from opioid drug abuse, asking companies that make and distribute the painkillers to review the risks their businesses could face from their role in the sector. Leaders of a 30-fund group that includes state pension officials and religious and labor organizations plan to reveal on Monday they have begun filing shareholder resolutions at 10 companies, including distributors AmerisourceBergen Corp. and Cardinal Health Inc. and manufacturers Johnson & Johnson and Insys Therapeutics.



from Biotech News